Pinkus Tober‐Lau
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 11
- COVID-19 Clinical Research Studies 9
- Virology top 10%
- Poxvirus research and outbreaks 3
- Modeling and Simulation top 10%
- Animal Science and Zoology top 10%
-
- Mosquito-borne diseases and control 3
- Malaria Research and Control 3
-
- Advanced Proteomics Techniques and Applications 2
-
- Heparin-Induced Thrombocytopenia and Thrombosis 2
-
- Pneumonia and Respiratory Infections 2
- Co-authors
- Florian KurthLeif Erik SanderFlorian KleinKanika VanshyllaHenning GruellPhilipp SchommersDavid HillusClara Lehmann
- Cited by
- Infectious DiseasesVirologyHealth
- Journals
- Angewandte Chemie International Edition (1 paper)Nature Medicine (1 paper)The Journal of Infectious Diseases (1 paper)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Pinkus Tober‐Lau
22 papers receiving 577 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Infectious Diseases 429
- Virology 63
- Health 46
- Modeling and Simulation 23
- Animal Science and Zoology 42
Countries citing papers authored by Pinkus Tober‐Lau
This map shows the geographic impact of Pinkus Tober‐Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pinkus Tober‐Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pinkus Tober‐Lau more than expected).
Fields of papers citing papers by Pinkus Tober‐Lau
This network shows the impact of papers produced by Pinkus Tober‐Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pinkus Tober‐Lau. The network helps show where Pinkus Tober‐Lau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pinkus Tober‐Lau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 16 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 15 | |
| 11 | 2022 | 25 | |
| 12 | mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variantbreakdown → | 2022 | 243 |
| 13 | 2022 | 11 | |
| 14 | 2022 | 42 | |
| 15 | 2022 | 2 | |
| 16 | 2022 | 46 | |
| 17 | 2022 | 20 | |
| 18 | 2021 | 58 | |
| 19 | 2021 | 40 | |
| 20 | 2019 | 9 |
About Pinkus Tober‐Lau
Pinkus Tober‐Lau is a scholar working on Infectious Diseases, Virology and Applied Microbiology and Biotechnology, having authored 27 papers that have together received 581 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (9 papers), Mosquito-borne diseases and control (3 papers), Poxvirus research and outbreaks (3 papers), Malaria Research and Control (3 papers), Advanced Proteomics Techniques and Applications (2 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Infectious Diseases (429 citations), Virology (63 citations) and Health (46 citations). Pinkus Tober‐Lau has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Florian Kurth, Leif Erik Sander, Florian Klein, Kanika Vanshylla, Henning Gruell, Philipp Schommers, David Hillus, Clara Lehmann, Markus Ralser and Victor M. Corman. Their work appears in journals such as Angewandte Chemie International Edition, Nature Medicine and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.